×
Back to Agenda
Session 7: Decentralized, Virtual and Remote Trials
Session Chair(s)
Scott Askin, MSC
Global Program Regulatory Director, Novartis Pharma AG, Switzerland
Francesca Cerreta, PHARMD, MPHARM, MS
Principal Scientific Officer, European Medicines Agency, Netherlands
Session 6: Decentralized, virtual and remote trials
Speaker(s)
Scott Askin, MSC
Global Program Regulatory Director, Novartis Pharma AG, Switzerland
Introduction: Current Regulation and Guidance
Andy Fischer
President, ISfTeH & CEO, Medgate, Switzerland
TeleMedicine: Setting the Standards in Remote Trials?
M. Khair ElZarrad, PHD, MPH
Vice President, Regulatory Policy, BridgeBio, United States
FDA’s Perspective on Innovative Clinical Trial Designs using Digital Tools
Francesca Cerreta, PHARMD, MPHARM, MS
Principal Scientific Officer, European Medicines Agency, Netherlands
Decentralized, virtual and remote trials – How is the EU enabling success
Have an account?